Haryana government restricted sale of Remdesivir and other drugs sale

Apr 28, 2021 20:31 | Haryana

Chandigarh, April 28: While considering the emergency and unmet medical need for COVID-19 disease, Haryana Government has issued directions for restricted sale, distribution of experimental drugs like injection Remdesivir  and Injection Tociluzimab use to treat patients with severe COVID-19 infection so as to stop irrational use.




Giving more  information  in this regard here today, a spokesperson of Food and Drug Administration said that keeping in view the emergency and unmet medical need for COVID-19 disease, Central Drugs Standard Control Organization (CDSCO) has approved Restricted Emergency Use of Remdesivir Injectable Formulations for treatment of patients with severe COVID-19 infection.




He said that Government has also issued directions that  Remdesivir formulations are required to be sold under the prescription of medical specialists only, Further, Remdesivir formulations are required to be supplied for use only to the hospital/ institutions to ensure proper use of the drugs as recommended.




He said that it has been reported that during COVID-19 Pandemic, doctors are irrationally prescribing the injection Remdesivir which is approved an Emergency Drug by Drugs Controller General of India and to be used in only patients having ICU beds/ ventilator for COVID-19 patients management and therefore it should not be prescribed by doctors for patients not admitted in hospitals or home isolated patients, having no ICU/ ventilators and not prescribed for conditions for which these drugs are not approved.





The spokesperson further said that irregular sale of Injection Remdesivir or Injection Tociluzimab is punishable under Drugs and Cosmetics Act for which Drug Licenses may be suspended or cancelled. Besides this, any black marketing/ hoarding of these drugs are cognizable and punishable offences for which stringent action of registration of FIR will be taken. He said that since the drugs are essentially required for management of COVID patients and  the misuse and violation of various Provisions of IPC, Epidemic Act, Disaster Management Act.





The spokesperson said that that all the sellers of these drugs have been directed to strictly comply with the provisions of the Drugs and Drugs Price Control Order (DPCO) read with the Essential Commodities Act along with sending  the details of all purchases and distributions to the State Drugs Controller, Haryana in the office of Commissioner, Food and Drugs Administration, Panchkula. Besides this, they have been directed to restrict sales to dedicated COVID-19 hospitals only, which have ICU beds and critical care facility is provided for management of COVID-19 patients.




         He said that the drug dealers have also been asked to keep a record of the  corona report, an indoor card having mentioned name of the drug  and record of the ID card / Aadhaar card for inspection purposes.